John A. Levi
Impact in
- Oncology top 1%
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
- Cancer Diagnosis and Treatment
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 36
- Neutropenia and Cancer Infections 11
- Cancer Treatment and Pharmacology 10
-
- Lung Cancer Treatments and Mutations 6
- Gastric Cancer Management and Outcomes 5
- Co-authors
- Peter H. Wiernik (11 shared papers)Walter O. Spitzer (1 shared paper)B. R. Catchlove (1 shared paper)Renaldo N. Battista (1 shared paper)Jane Hall (1 shared paper)Annette J. Dobson (1 shared paper)David Bell (15 shared papers)Robert L. Woods (13 shared papers)
- Journals
- The Medical Journal of Australia (12 papers)Cancer (11 papers)Journal of Clinical Oncology (5 papers)Pathology (3 papers)Investigational New Drugs (3 papers)
- Partner nations
- AustraliaUnited StatesIsrael
In The Last Decade
John A. Levi
98 papers receiving 3.9k citations
John A. Levi's Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 1.4k
- Pathology and Forensic Medicine 581
- Pulmonary and Respiratory Medicine 817
- Genetics 239
- Dermatology 161
Countries citing papers authored by John A. Levi
This map shows the geographic impact of John A. Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Levi more than expected).
Fields of papers citing papers by John A. Levi
This network shows the impact of papers produced by John A. Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Levi. The network helps show where John A. Levi may publish in the future.
Co-authors
The 25 scholars most cited alongside John A. Levi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Measuring the quality of life of cancer patients Hit paper breakdown → | 1981 | 1210 |
| 2 | 1987 | 308 | |
| 3 | 1999 | 171 | |
| 4 | 1997 | 150 | |
| 5 | 1980 | 125 | |
| 6 | 1990 | 114 | |
| 7 | 1980 | 112 | |
| 8 | 2001 | 108 | |
| 9 | 2000 | 86 | |
| 10 | 1975 | 80 | |
| 11 | 1999 | 64 | |
| 12 | 1997 | 64 | |
| 13 | 1973 | 63 | |
| 14 | 1973 | 62 | |
| 15 | 1981 | 61 | |
| 16 | 1986 | 60 | |
| 17 | 1974 | 59 | |
| 18 | 1977 | 57 | |
| 19 | 2010 | 49 | |
| 20 | 1988 | 48 |
About John A. Levi
John A. Levi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 99 papers that have together received 4.2k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (11 papers), Cancer Treatment and Pharmacology (10 papers), Lymphoma Diagnosis and Treatment (10 papers), Testicular diseases and treatments (9 papers), Palliative Care and End-of-Life Issues (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer therapeutics and mechanisms (6 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Oncology (1.4k citations), Pathology and Forensic Medicine (581 citations), Pulmonary and Respiratory Medicine (817 citations), Genetics (239 citations) and Dermatology (161 citations). John A. Levi has collaborated with scholars based in Australia, United States and Israel. Frequent co-authors include Peter H. Wiernik, Walter O. Spitzer, B. R. Catchlove, Renaldo N. Battista, Jane Hall, Annette J. Dobson, David Bell, Robert L. Woods, D. Dalley and Nick Pavlakis. Their work appears in journals such as The Medical Journal of Australia, Cancer, Journal of Clinical Oncology, Pathology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.